Related Experiment Video
Updated: Apr 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Reasons for Treatment Changes in Patients With Moderate to Severe Psoriasis
Kathryn L Anderson1, Steven R Feldman2
1Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA anderson.kathryn.lee@gmail.com.
Background:
Psoriasis treatment involves multiple treatment arms. Treatment choice depends on many factors and may change, due to the chronicity of psoriasis.
Objective:
The purpose of our study is to explore reasons for treatment changes in patients with moderate to severe psoriasis.
Methods:
Ten charts of patients with moderate to severe psoriasis were reviewed. The medication changes and reasons for change were extracted. A "treatment change" was defined as switching between medication classes, adding or removing a medication class, or switching medications within the oral or biologic medication class.
Results:
Seventy-seven treatment changes were identified. On average, 1 treatment change occurred per year of follow-up. The most common reason for treatment change was inadequate disease control.
Conclusions:
Inadequate disease control with current therapy is the most common reason a physician changes treatment for moderate to severe psoriasis. More efficacious treatments or ways to improve efficacy may help improve the long-term outcomes of psoriasis.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Atherosclerosis III: Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Acne Infection
